Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
ACS Infectious Diseases|April 10, 2024
Evaluation of Fusobacterium nucleatum Enoyl-ACP Reductase (FabK) as a Narrow-Spectrum Drug TargetJacob T Rutherford, Kristiana Avad, Chetna Dureja, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2024
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategyChetna Dureja, Jacob T Rutherford, Fahad B A Pavel, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) Inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategyChetna Dureja, Jacob T Rutherford, Fahad B A Pavel, et al.
Bioorganic & Medicinal Chemistry|May 24, 2023
Synthesis and evaluation of phenylimidazole FabK inhibitors as new Anti-C. Difficile agentsKrissada Norseeda, Fahad Bin Aziz Pavel, Jacob T Rutherford, et al.
Cell|January 13, 2015
A qrr noncoding RNA deploys four different regulatory mechanisms to optimize quorum-sensing dynamicsLihui Feng, Steven T Rutherford, Kai Papenfort, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategiesM A Andrew, T R Easterling, D B Carr, et al.
Oncogene|April 15, 2008
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cellsR Chen, A B Alvero, D A Silasi, et al.
Pageof 7